Publications by authors named "Chika Nitani"

Claim this Profile
R
Recurrent Annular Erythema as an Initial Presentation of Pediatric Histiocytoid Sweet Syndrome Associated With Myelodysplastic Syndrome: A Case Report.
Nao Kusutani, Chika Nitani, Kazuyoshi Fukai

J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Phase II study of glucarpidase in Japanese patients with delayed methotrexate clearance after high-dose methotrexate therapy].
Keiko Okada, Chitose Ogawa, Rishu Kayatani, Sakiko Azuma, Natsumi Kikuchi, Chika Nitani

Rinsho Ketsueki· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Long-term remission achieved with allogeneic hematopoietic stem cell transplantation at first complete remission in a pediatric patient with TCF7::SPI1 fusion-positive T-cell acute lymphoblastic leukemia].
Mayuko Noguchi, Kai Yamasaki, Sakiko Azuma, Natsumi Kikuchi, Chika Nitani

Rinsho Ketsueki· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Tamibarotene in Pediatric and Young Adult Patients with Recurrent or Refractory Solid Tumors.
Takuya Azechi, Yutaka Fukaya, Chika Nitani, Junichi Hara, Hiroshi Kawamoto

Curr Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation.
Junichi Hara, Chika Nitani, Hiroyuki Shichino, Tatsuo Kuroda, Tomoro Hishiki

Jpn J Clin Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could the immune checkpoint inhibitor against colorectal cancer in constitutional mismatch repair deficiency syndrome prevent new cancer formation?
Kazuki Tanimura, Kai Yamasaki, Kohei Matsubara, Mayuko Noguchi, Natsumi Kikuchi, Chika Nitani

Pediatr Blood Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of a synthetic retinoid and a DNA demethylating agent induced differentiation of neuroblastoma through retinoic acid signal reprogramming.
Naoko Hattori, Kiyoshi Asada, Nozomu Miyajima, Akiko Mori, Yoko Nakanishi, Chika Nitani

Br J Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors.
Chika Nitani, Junichi Hara, Hiroshi Kawamoto, Tomoaki Taguchi, Toshimi Kimura

Cancer Chemother Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I/IIa Study of Antidisialoganglioside Antibody Dinutuximab in Japanese Patients With Neuroblastoma.
Junichi Hara, Chika Nitani, Hiroshi Kawamoto, Tomoaki Taguchi, Toshimi Kimura

J Pediatr Hematol Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Gemcitabine and Docetaxel for the Treatment of Relapsed and Refractory Malignant Rhabdoid Tumor of Kidney and Atypical Teratoid Rhabdoid Tumor].
Kohei Matsubara, Kai Yamasaki, Kazuki Tanimura, Kota Hira, Yuki Okuhiro, Chika Nitani

Gan To Kagaku Ryoho· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Kazuki Tanimura, Kai Yamasaki, Yuki Okuhiro, Kota Hira, Chika Nitani

Case Rep Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the NCCV Cocktail-1 vaccine for refractory pediatric solid tumors: A phase I clinical trial.
Yu Akazawa, Ako Hosono, Toshiaki Yoshikawa, Hide Kaneda, Chika Nitani

Cancer Sci· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-conditioning regimen consisting of high-dose thiotepa and melphalan with autologous stem cell rescue for high-risk pediatric solid tumors: A second report.
Keiko Okada, Kai Yamasaki, Chika Nitani, Hiroyuki Fujisaki, Yuko Osugi

Pediatr Blood Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary osteosarcoma in patients previously treated for childhood cancer: Three case reports.
Akiyoshi Shimatani, Masanari Aono, Manabu Hoshi, Naoto Oebisu, Tadashi Iwai, Chika Nitani

Mol Clin Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.
Nobuhiro Tsuchiya, Ako Hosono, Toshiaki Yoshikawa, Kayoko Shoda, Kazuto Nosaka, Chika Nitani

Oncoimmunology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects.
Kazuo Umemura, Takayuki Iwaki, Toshimi Kimura, Chitose Ogawa, Takahiro Fukuda, Chika Nitani

Clin Pharmacol Drug Dev· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib treatment in children with relapsed and refractory neuroblastoma: an experience of four cases.
Keiko Okada, Yoshiko Nakano, Kai Yamasaki, Chika Nitani, Hiroyuki Fujisaki

Cancer Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis